U.MIR PHARMA LTD

Company Registration Number:
07321929 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2025

Period of accounts

Start date: 01 August 2024

End date: 31 July 2025

U.MIR PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 July 2025

Balance sheet
Notes

U.MIR PHARMA LTD

Balance sheet

As at 31 July 2025


Notes
2025
2024


£
£
Fixed assets
Intangible assets: 3 10,251 14,015
Tangible assets: 4 132,608 164,686
Investments: 5 167,500 167,500
Total fixed assets: 310,359 346,201
Current assets
Stocks: 77,455 71,000
Debtors: 6 136,321 198,010
Cash at bank and in hand: 28,751 71,135
Total current assets: 242,527 340,145
Creditors: amounts falling due within one year:   (267,919) (317,075)
Net current assets (liabilities): (25,392) 23,070
Total assets less current liabilities: 284,967 369,271
Creditors: amounts falling due after more than one year:   (162,088) (202,231)
Total net assets (liabilities): 122,879 167,040
Capital and reserves
Called up share capital: 2,002 2,002
Profit and loss account: 120,877 165,038
Shareholders funds: 122,879 167,040

The notes form part of these financial statements

U.MIR PHARMA LTD

Balance sheet statements

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 20 April 2026
and signed on behalf of the board by:

Name: Usman Mir
Status: Director

The notes form part of these financial statements

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

2. Employees

2025 2024
Average number of employees during the period 21 18

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

3. Intangible Assets

Total
Cost £
At 01 August 2024 37,635
At 31 July 2025 37,635
Amortisation
At 01 August 2024 23,620
Charge for year 3,764
At 31 July 2025 27,384
Net book value
At 31 July 2025 10,251
At 31 July 2024 14,015

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

4. Tangible Assets

Total
Cost £
At 01 August 2024 354,630
At 31 July 2025 354,630
Depreciation
At 01 August 2024 189,944
Charge for year 32,078
At 31 July 2025 222,022
Net book value
At 31 July 2025 132,608
At 31 July 2024 164,686

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

5. Fixed investments

Investments are included in the balance sheet at cost less any provision for impairment. The Company assess investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. If such an indication of impairment exists, the Company makes an estimate of the recoverable amount of the investment. If the recoverable amount is less than the value of the investment, the investment is written down to the recoverable amount. An impairment loss is recognised immediately in the profit and loss account. If the impairment is not considered to be a permanent diminution in value it may reverse in a future period to the extent that it is no longer considered necessary.

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

6. Debtors

2025 2024
££
Debtors due after more than one year: 136,321 198,010